# Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)

> **NIH NIH N01** · GRYPHON SCIENTIFIC, LLC · 2022 · $802,459

## Abstract

This contract will provide support for the ongoing survey of chemical and biological information for potential therapeutic compounds for HIV, tuberculosis (TB), hepatitis B virus (HBV). The resulting information and associated analytical tools are critical for the rational selection and discovery of potential therapies for HIV, TB, and HBV.

## Key facts

- **NIH application ID:** 10629145
- **Project number:** 75N93020C00031-P00003-9999-1
- **Recipient organization:** GRYPHON SCIENTIFIC, LLC
- **Principal Investigator:** LOUISE SUMNER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $802,459
- **Award type:** —
- **Project period:** 2021-09-30 → 2022-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10629145

## Citation

> US National Institutes of Health, RePORTER application 10629145, Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB) (75N93020C00031-P00003-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10629145. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*